Health & Medicine
Major Availability Breakthrough For AIDS Drug Nevirapine
Kathleen Lees
First Posted: Jan 08, 2015 04:13 PM EST
Researchers have made a "major breakthrough" in developing a more cost-effective way to manufacture a widely used AIDS drug that will help make it available in more countries dealing with economic issues.
As it stands, researchers from the University of Washington, Florida State University and the Massachusetts Institute of Technology are in the first phase of the completing the project, which involves transferring the technology to The Clinton Foundation for outsourcing the improvements to existing pharmaceutical manufacturers.
"We completed the first phase and we've gotten the chemistry to where it's probably the lowest-cost process you could imagine, using really cheap, inexpensive raw materials and streamlining the chemistry for the process," said lead researcher B. Frank Gupton, in a staement. "We've reported our results to the Gates Foundation and I believe that they were very pleased with our progress."
The involved team of researchers are part of the Medicine of All Initiative that's funded by a $4.4 million grant from the Bill & Melinda Gates Foundation.
"We've had a major breakthrough," Gupton added, via Medical Xpress. "We have developed a much more cost-effective way to produce this drug."
For more great nature science stories and general news, please visit our sister site, Headlines and Global News (HNGN).
See Now:
NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone
TagsHealth ©2024 ScienceWorldReport.com All rights reserved. Do not reproduce without permission. The window to the world of science news.
More on SCIENCEwr
First Posted: Jan 08, 2015 04:13 PM EST
Researchers have made a "major breakthrough" in developing a more cost-effective way to manufacture a widely used AIDS drug that will help make it available in more countries dealing with economic issues.
As it stands, researchers from the University of Washington, Florida State University and the Massachusetts Institute of Technology are in the first phase of the completing the project, which involves transferring the technology to The Clinton Foundation for outsourcing the improvements to existing pharmaceutical manufacturers.
"We completed the first phase and we've gotten the chemistry to where it's probably the lowest-cost process you could imagine, using really cheap, inexpensive raw materials and streamlining the chemistry for the process," said lead researcher B. Frank Gupton, in a staement. "We've reported our results to the Gates Foundation and I believe that they were very pleased with our progress."
The involved team of researchers are part of the Medicine of All Initiative that's funded by a $4.4 million grant from the Bill & Melinda Gates Foundation.
"We've had a major breakthrough," Gupton added, via Medical Xpress. "We have developed a much more cost-effective way to produce this drug."
For more great nature science stories and general news, please visit our sister site, Headlines and Global News (HNGN).
See Now: NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone